Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Yeghiazarians, Yerem

Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition. [electronic resource] - Cytotherapy Feb 2012 - 223-31 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1477-2566

10.3109/14653249.2011.623690 doi


Animals
Apoptosis
Cell Differentiation
Disease Models, Animal
Embryonic Stem Cells--cytology
Enzyme Activation--drug effects
Fibroblasts--cytology
Heart Ventricles--physiopathology
Humans
Imidazoles--pharmacology
Immunohistochemistry
Injections--methods
Mice
Mice, SCID
Mitogen-Activated Protein Kinase 14--antagonists & inhibitors
Myocardial Infarction--therapy
Myocytes, Cardiac--cytology
Pyridines--pharmacology
Teratoma--metabolism